{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:55:22Z","timestamp":1790585722405,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to develop and validate a\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose PET\/computed tomography (CT)-based radiomics model for predicting\n                      <jats:italic toggle=\"yes\">BRCA<\/jats:italic>\n                      mutation status in patients with advanced high-grade serous ovarian cancer (HGSOC).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective study of 124 patients with HGSOC who underwent preoperative PET\/CT scans and\n                      <jats:italic toggle=\"yes\">BRCA<\/jats:italic>\n                      mutation testing was conducted. The cohort was divided into training and internal validation sets using a 7\u2005:\u20053 ratio. An external validation set of 25 patients was used to confirm model generalizability. Radiomic features were extracted from PET and CT images and used to build predictive models using logistic regression, random forest, support vector machine, and decision tree classifiers. The models were evaluated for their predictive performance using metrics such as the area under the receiver operating characteristic curve (AUC), accuracy, precision, sensitivity, and F1 score. A combined model incorporating radiomics, PET\/CT metabolic parameters, and clinical variables was also constructed. In addition, the radiomics models were used to predict progression-free survival (PFS) and overall survival in the training and internal validation cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The logistic regression model showed the best performance, with AUCs of 94.79, 87.37, and 85.06% in the training, internal, and external validation cohorts, respectively. The combined model achieved the highest AUCs of 0.968, 0.932, and 0.960 in the training, internal validation, and external validation cohorts, respectively. Significant differences in PFS between risk groups were observed, while overall survival differences were not statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The PET\/CT-based radiomics model accurately predicts\n                      <jats:italic toggle=\"yes\">BRCA<\/jats:italic>\n                      mutation status in HGSOC, potentially aiding in personalized treatment strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002245","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:00:29Z","timestamp":1790582429000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["18F-FDG PET\/CT radiomics for prediction of BRCA mutations in high-grade serous ovarian cancer"],"prefix":"10.1097","author":[{"given":"Fangmei","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Gynecology, Shangyu People\u2019s Hospital of Shaoxing, Shaoxing University, Shaoxing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Second Affiliated Hospital, Shandong First Medical University, Shandong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Universal Cloud Medical Imaging Diagnostic Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Universal Cloud Medical Imaging Diagnostic Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wu","sequence":"additional","affiliation":[{"name":"Shanghai Universal Cloud Medical Imaging Diagnostic Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[{"name":"Zhouxin Medical Imaging Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6915-5225","authenticated-orcid":false,"given":"Ruoyao","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"R1-20260928","first-page":"17","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R2-20260928","first-page":"280","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine.","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R3-20260928","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole\u2013genome characterization of chemoresistant ovarian cancer.","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"R4-20260928","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1078-0432.CCR-14-1816","article-title":"Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.","volume":"21","author":"Zhong","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R5-20260928","first-page":"609","article-title":"Integrated genomic analyses of ovarian carcinoma.","volume":"474","year":"2012","journal-title":"Nature"},{"key":"R6-20260928","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R7-20260928","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/S1470-2045(22)00139-5","article-title":"Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.","volume":"23","author":"Vergote","year":"2022","journal-title":"Lancet Oncol"},{"key":"R8-20260928","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1148\/radiol.2017161870","article-title":"Radiogenomics of high-grade serous ovarian cancer: multireader multi-institutional study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.","volume":"285","author":"Vargas","year":"2017","journal-title":"Radiology"},{"key":"R9-20260928","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2967\/jnumed.118.222893","article-title":"Introduction to radiomics.","volume":"61","author":"Mayerhoefer","year":"2020","journal-title":"J Nucl Med"},{"key":"R10-20260928","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine.","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"R11-20260928","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data.","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"R12-20260928","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1007\/s00330-020-06993-5","article-title":"MR imaging of epithelial ovarian cancer: a combined model to predict histologic subtypes.","volume":"30","author":"Qian","year":"2020","journal-title":"Eur Radiol"},{"key":"R13-20260928","doi-asserted-by":"crossref","first-page":"e2245141","DOI":"10.1001\/jamanetworkopen.2022.45141","article-title":"Computed tomographic radiomics in differentiating histologic subtypes of epithelial ovarian carcinoma.","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Network Open"},{"key":"R14-20260928","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1007\/s00330-019-06124-9","article-title":"Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study.","volume":"29","author":"Zhang","year":"2019","journal-title":"Eur Radiol"},{"key":"R15-20260928","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1038\/s41467-023-41820-7","article-title":"Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.","volume":"14","author":"Crispin-Ortuzar","year":"2023","journal-title":"Nat Commun"},{"issue":"Pt A)","key":"R16-20260928","doi-asserted-by":"crossref","first-page":"109335","DOI":"10.1016\/j.intimp.2022.109335","article-title":"Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer.","volume":"113","author":"Gao","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R17-20260928","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1002\/mp.16730","article-title":"CT-based radiomics prediction of CXCL13 expression in ovarian cancer.","volume":"50","author":"Xu","year":"2023","journal-title":"Med Phys"},{"key":"R18-20260928","doi-asserted-by":"crossref","first-page":"16397","DOI":"10.1038\/s41598-023-43543-7","article-title":"A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer.","volume":"13","author":"Zhan","year":"2023","journal-title":"Sci Rep"},{"key":"R19-20260928","doi-asserted-by":"crossref","first-page":"948767","DOI":"10.3389\/fphys.2022.948767","article-title":"Habitat radiomics analysis of PET\/CT imaging in high-grade serous ovarian cancer: application to Ki-67 status and progression-free survival.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Physiol"},{"key":"R20-20260928","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.3390\/cancers14112739","article-title":"CT-based radiomics and deep learning for BRCA mutation and progression-free survival prediction in ovarian cancer using a multicentric dataset.","volume":"14","author":"Avesani","year":"2022","journal-title":"Cancers"},{"key":"R21-20260928","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1177\/02841851231188915","article-title":"CT-based radiomics nomogram analysis for assessing BRCA mutation status in patients with high-grade serous ovarian cancer.","volume":"64","author":"Cao","year":"2023","journal-title":"Acta Radiol"},{"key":"R22-20260928","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12880-021-00711-3","article-title":"Prediction of BRCA gene mutation status in epithelial ovarian cancer by radiomics models based on 2D and 3D CT images.","volume":"21","author":"Mingzhu","year":"2021","journal-title":"BMC Med Imaging"},{"key":"R23-20260928","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","article-title":"Diagnosis and staging of primary ovarian cancer: correlation between PET\/CT, Doppler US, and CT or MRI.","volume":"116","author":"Nam","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R24-20260928","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/diagnostics11020380","article-title":"A systematic review of PET textural analysis and radiomics in cancer.","volume":"11","author":"Pi\u00f1eiro-Fiel","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R25-20260928","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1007\/s00259-019-04391-8","article-title":"Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis.","volume":"46","author":"Zwanenburg","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R26-20260928","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0.","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R27-20260928","doi-asserted-by":"crossref","first-page":"638124","DOI":"10.3389\/fonc.2021.638124","article-title":"Radiomics analysis of PET and CT components of F-FDG PET\/CT imaging for prediction of progression-free survival in advanced high-grade serous ovarian cancer.","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"R28-20260928","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.3390\/diagnostics13223394","article-title":"Prognostic 18F-FDG radiomic features in advanced high-grade serous ovarian cancer.","volume":"13","author":"Travaglio","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R29-20260928","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.3390\/tomography8060222","article-title":"Relationship between baseline [F]FDG PET\/CT semiquantitative parameters and BRCA mutational status and their prognostic role in patients with invasive ductal breast carcinoma.","volume":"8","author":"Dondi","year":"2022","journal-title":"Tomography"},{"key":"R30-20260928","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.3390\/cancers12123584","article-title":"BRCA1\/2 variants and metabolic factors: results from a cohort of Italian female carriers.","volume":"12","author":"Oliverio","year":"2020","journal-title":"Cancers"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:00:32Z","timestamp":1790582432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002245","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"2026-03-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}